NewAmsterdam Pharma Company N.V. (NAMS) Earnings
|
Expand Research on NAMS
| Next EPS Date | 8/12/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +25.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +5.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/26  |
Q226 | N/A | -$0.49 | N/A | N/A | $1.66M | N/A | N/A | N/A | ||
| 5/7/26 | Q126 | $0.00 | -$0.49 | +$0.49 | $3.04M | $1.18M | N/A |  | | Details | |
| 3/4/26 |
Q425 | N/A | -$0.40 | N/A | N/A | $2.88M | N/A | N/A | N/A | ||
| 11/17/25 |
Q325 | N/A | -$0.40 | N/A | N/A | $5.31M | N/A | N/A | N/A | ||
| 8/12/25 |
Q225 | N/A | -$0.49 | N/A | N/A | $2.13M | N/A | N/A | N/A | ||
| 5/9/25 |
Q125 | N/A | -$0.50 | N/A | N/A | $1.53M | N/A | N/A | N/A | ||
| 5/7/25 |
Q125 | N/A | -$0.50 | N/A | N/A | $1.53M | N/A | N/A | N/A | ||
| 3/28/25 |
Q424 | N/A | -$0.51 | N/A | N/A | $1.73M | N/A | N/A | N/A |
